Harvard Bioscience
(HBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,749 | 20,681 | 20,285 | 18,655 | 17,237 |
| Receivables | 18,858 | 18,976 | 16,598 | 17,973 | 18,986 |
| Inventories | 17,725 | 17,762 | 17,992 | 17,746 | 18,382 |
| Income taxes - deferred | 1,551 | 1,553 | 3,887 | 3,929 | 3,913 |
| TOTAL | $61,883 | $58,972 | $58,762 | $58,303 | $58,518 |
| Non-Current Assets | |||||
| PPE Net | 4,424 | 4,551 | 4,097 | 3,778 | 3,853 |
| Intangibles | 57,186 | 58,701 | 59,019 | 59,109 | 60,900 |
| Other Non-Current Assets | 11,944 | 11,260 | 8,702 | 8,341 | 8,236 |
| TOTAL | $73,554 | $74,512 | $71,818 | $71,228 | $72,989 |
| Total Assets | $135,437 | $133,484 | $130,580 | $129,531 | $131,507 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,000 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,429 | 4,680 | 4,141 | 4,607 | 4,920 |
| Accrued Expenses | 4,323 | 4,011 | 4,204 | 3,409 | 3,938 |
| Other current liabilities | 778 | 728 | 601 | 1,327 | 1,233 |
| TOTAL | $13,116 | $9,901 | $9,531 | $9,913 | $10,729 |
| Non-Current Liabilities | |||||
| Long Term Debt | 12,000 | 12,950 | 15,300 | 16,100 | 16,800 |
| Deferred Revenues | 586 | 482 | 585 | 570 | 638 |
| Other Non-Current Liabilities | 5,659 | 6,143 | 4,850 | 4,819 | 5,138 |
| TOTAL | $17,939 | $19,370 | $20,687 | $21,603 | $22,670 |
| Total Liabilities | $31,055 | $29,271 | $30,218 | $31,516 | $33,399 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,062 | 30,009 | 28,823 | 28,793 | 28,768 |
| Common Shares | 374 | 370 | 364 | 364 | 363 |
| Retained earnings | -77,164 | -77,260 | -78,462 | -78,331 | -79,101 |
| Other shareholders' equity | -6,568 | -4,531 | -4,402 | -5,846 | -4,128 |
| TOTAL | $104,382 | $104,213 | $100,362 | $98,015 | $98,108 |
| Total Liabilities And Equity | $135,437 | $133,484 | $130,580 | $129,531 | $131,507 |